About
EndoGI Medical is a medical device company developing a multiple stent placement delivery system for the treatment of biliary and pancreatic duct stenosis and strictures caused by cancer, injury, inflammation, cholangitis, or gallstones.
The EndoGI system enables the insertion and placement of two or more plastic stents in the common bile or hepatic ducts with one passage of the delivery system while securing and maintaining access using a guide wire at the targeted anatomical site.
In July 2020, EndoGI Medical received FDA approval for its technology, which enables the possibility of inserting two stents simultaneously into the bile ducts connected to the pancreas, significantly reducing the danger of exposing patients to infections and other life-threatening situations caused by the repetitive insertions of singular stents.
Following the FDA approval, the company is focusing on receiving approval from the Israeli Health Ministry and marketing the technology for clinical use in Israel and the United States.
Funding history · 2 rounds · $55K total
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is EndoGI Medical's core product development?
- EndoGI Medical is developing a multiple stent placement delivery system for the treatment of biliary and pancreatic duct stenosis and strictures.
- When did EndoGI Medical receive FDA approval for its technology?
- In July 2020, EndoGI Medical received FDA approval for its technology, which allows for the simultaneous insertion of two stents into bile ducts.
- What is EndoGI Medical's current focus following FDA approval?
- Following FDA approval, EndoGI Medical is focusing on receiving approval from the Israeli Health Ministry and marketing its technology for clinical use in Israel and the United States.
- When was EndoGI Medical founded?
- EndoGI Medical was founded in May 2017.
- Where is EndoGI Medical headquartered?
- EndoGI Medical is headquartered in Nazareth, Israel.
- What was EndoGI Medical's total raised capital according to startupim data?
- EndoGI Medical has a total raised capital of $54,682 USD, which includes a grant.
- Which investor participated in EndoGI Medical's Undisclosed round in April 2019?
- NGT3 participated in EndoGI Medical's Undisclosed round in April 2019.
- Which investor participated in EndoGI Medical's Series A round in August 2022?
- NGT HealthCare II participated in EndoGI Medical's Series A round in August 2022.
- How many employees does EndoGI Medical currently have?
- EndoGI Medical currently has 5 employees.